Sandra N.
- Country
- Belgium
- Department
- Radiotherapy-Oncology
Research Overview
- Phase II Randomized Study of Cisplatin and Radiotherapy Versus Durvalumab and Radiotherapy in Intermediate-Risk HPV-Positive Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma
- Phase 3 Evaluation of Intratumoral NBTXR3 with Radiotherapy ± Cetuximab in Platinum-Ineligible Elderly Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma
Data & Insights
Has run more than one trial at 4 of 54 partner sites.
Specializations
Oncology Focus
Specializes in the treatment of oropharyngeal squamous cell carcinoma, with particular emphasis on HPV-positive cases affecting the head and neck region.
- Head and Neck Cancer Treatment
- HPV-Related Malignancies
- Locoregionally Advanced Cancer Care
Investigates innovative therapeutic approaches for intermediate risk oropharyngeal cancer patients.
Therapeutic Expertise
Focuses on combining radiotherapy treatments with various therapeutic agents, including both traditional chemotherapy and innovative immunotherapy approaches.
- Radiation Therapy Applications
- Immunotherapy Integration
- Combination Treatment Strategies
Explores optimization of treatment sequences in advanced oropharyngeal cancer management.
Clinical Innovation
Evaluates survival outcomes through various treatment combinations, incorporating both standard-of-care and novel therapeutic approaches.
- Event-Free Survival Assessment
- Treatment Response Evaluation
- Risk-Stratified Therapy
Develops treatment strategies for intermediate risk cancer patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.